|
Hubert E. Huckel, MD, is a founding shareholder and has been a director of Catalyst since its formation in January 2002. He spent 29 years with The Hoechst Group (now Sanofi Aventis), and was at the time of his retirement Executive Chairman of the Board of Hoechst-Roussel Pharmaceuticals, Inc. Dr. Huckel has continued his involvement in the pharmaceutical industry and currently serves on the boards of directors of Titan Pharmaceuticals, Inc., ThermoGenesis Corp. and Valera Pharmaceuticals, Inc. Dr. Huckel is Executive Chairman and a director of Concordia Pharmaceuticals, Inc. Dr. Huckel received his MD degree from the University of Vienna, Austria, and is a member of the Rockefeller University Council. | 